The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson’s disease: an observational study

BACKGROUND: Dopamine agonists (DA) are the first-choice drug for treatment of the early stage of Parkinson’s disease (PD) in subjects younger than 70 years. Recently, a number of third generation DA have been marketed, including transdermal patch of rotigotine and extended release oral formulation o...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Pellicano, Clelia, Benincasa, Dario, Fanciulli, Alessandra, Latino, Pamela, Giovannelli, Morena, Pontieri, Francesco E
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2013
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3880455/
https://ncbi.nlm.nih.gov/pubmed/24360350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-18-60
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы